<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002100782</identifier>
        </entity>
        <period>
            <startDate>2026-02-04</startDate>
            <endDate>2026-02-04</endDate>
        </period>
    </context>
    <context id="C_222a8c84-8feb-48ec-840a-58df0531e5a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002100782</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-04</startDate>
            <endDate>2026-02-04</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:CombinedProspectusTableNa
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_35d8c68d-9a9e-4246-879d-00a0eeebd629">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_44ac10cf-7f6f-4e80-8260-864b3eaad89d">0002100782</dei:EntityCentralIndexKey>
    <ffd:OffsetTableNa
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_471ed55b-b4da-4b09-9ad8-b575d614e983">N/A</ffd:OffsetTableNa>
    <ffd:FeeExhibitTp
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_afa7147a-4be8-4b49-9064-e9d609975854">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:FormTp
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_1eaf1ccc-a78e-4452-a041-60297a6fce6e">S-1</ffd:FormTp>
    <ffd:SubmissnTp
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_3a4d96bd-000b-4c3a-851d-02a43d3332cd">S-1</ffd:SubmissnTp>
    <dei:EntityRegistrantName
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      id="F_1b3ec733-71a8-4b1a-ba1c-614157ccc923">Generate Biomedicines, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      id="F_cb65691b-2a75-4034-8050-e4db97a403ba">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      id="F_4525563e-07d7-42d6-9ecf-5d51f09c1bd0">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      id="F_61c1801c-ff46-4b3f-9637-32f21f373933">Common Stock, par value $0.001 per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      id="F_142b54ca-9c0a-45c1-947a-1a8206d4a551">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      decimals="2"
      id="F_13548093-2a7d-46db-80f8-8ab82451314a"
      unitRef="U_USD">100000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      decimals="7"
      id="F_67744178-04f9-4d47-8e30-f5a55d793aee"
      unitRef="U_pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      decimals="2"
      id="F_28a2ad10-b275-4c51-b76a-723b1ffdf8cb"
      unitRef="U_USD">13810</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      decimals="2"
      id="F_ce9fff2f-8f31-4311-98a6-742a721a3af0"
      unitRef="U_USD">100000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      decimals="2"
      id="F_d2287b82-e978-45e6-98c3-fcde2582e8e4"
      unitRef="U_USD">13810</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      decimals="2"
      id="F_01cc3f63-91de-4d68-a296-ff5d0b5ed233"
      unitRef="U_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      decimals="2"
      id="F_0b958fb7-2da2-40de-9a6e-01e648f5512f"
      unitRef="U_USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="C_ea891d9e-dde9-40b4-8251-5668f0daa7d9"
      decimals="2"
      id="F_2cd7c02a-b7b5-4be2-ab95-22af71d50103"
      unitRef="U_USD">13810</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="C_222a8c84-8feb-48ec-840a-58df0531e5a2"
      id="F_a82075b0-dee1-48b1-bc35-f0a6e1570aa1">&lt;p style="margin-left:2.65pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Maximum Aggregate Offering Price estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. Includes the aggregate offering price of additional shares that the underwriters have the option to purchase from the registrant, if any.&lt;/span&gt;&lt;/p&gt;</ffd:OfferingNote>
</xbrl>
